Eris Lifesciences Ltd has sold its 100% holdings in Eris Oaknet Healthcare and Aprica Healthcare to its subsidiary Eris Therapeutics Limited for ₹8619.14 million, effective from March 6, 2025, with completion expected by March 31, 2025.
AI Assistant
ERIS Lifesciences Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.